BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26477395)

  • 1. Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.
    de Bree R; van der Putten L; van Tinteren H; Wedman J; Oyen WJ; Janssen LM; van den Brekel MW; Comans EF; Pruim J; Takes RP; Hobbelink MG; Valdés Olmos R; van der Laan BF; Boers M; Hoekstra OS; Leemans CR
    Radiother Oncol; 2016 Feb; 118(2):251-6. PubMed ID: 26477395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of PET scanning to improve diagnostic yield of direct laryngoscopy in patients with suspicion of recurrent laryngeal carcinoma after radiotherapy.
    de Bree R; van der Putten L; Hoekstra OS; Kuik DJ; Uyl-de Groot CA; van Tinteren H; Leemans CR; Boers M;
    Contemp Clin Trials; 2007 Nov; 28(6):705-12. PubMed ID: 17459783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method.
    Brouwer J; de Bree R; Comans EF; Akarriou M; Langendijk JA; Castelijns JA; Hoekstra OS; Leemans CR
    Radiother Oncol; 2008 May; 87(2):217-20. PubMed ID: 18329117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy.
    van Hooren AC; Brouwer J; de Bree R; Hoekstra OS; Leemans CR; Uyl-de Groot CA
    Eur Arch Otorhinolaryngol; 2009 Sep; 266(9):1441-8. PubMed ID: 19043728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
    Chan SC; Yen TC; Ng SH; Lin CY; Wang HM; Liao CT; Fan KH; Chang JT
    J Nucl Med; 2006 Sep; 47(9):1447-54. PubMed ID: 16954552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?
    Wedman J; Pruim J; van der Putten L; Hoekstra OS; de Bree R; van Dijk BAC; van der Laan BFAM
    Clin Otolaryngol; 2019 Mar; 44(2):124-130. PubMed ID: 30315624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy].
    Dietz A; Rudat V; Harms W; Jungehülsing M; Dollner R; Henze M
    HNO; 2004 Jan; 52(1):38-44. PubMed ID: 14740113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer.
    Terhaard CH; Bongers V; van Rijk PP; Hordijk GJ
    Head Neck; 2001 Nov; 23(11):933-41. PubMed ID: 11754496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement.
    Brouwer J; Bodar EJ; De Bree R; Langendijk JA; Castelijns JA; Hoekstra OS; Leemans CR
    Eur Arch Otorhinolaryngol; 2004 Sep; 261(8):417-22. PubMed ID: 14625779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
    Been LB; Hoekstra HJ; Suurmeijer AJ; Jager PL; van der Laan BF; Elsinga PH
    Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
    Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
    Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma.
    Liu FY; Lin CY; Chang JT; Ng SH; Chin SC; Wang HM; Liao CT; Chan SC; Yen TC
    J Nucl Med; 2007 Oct; 48(10):1614-9. PubMed ID: 17873135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
    Yao M; Graham MM; Smith RB; Dornfeld KJ; Skwarchuk M; Hoffman HT; Funk GF; Graham SM; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1410-8. PubMed ID: 15590172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-18 FDG PET scan after radiotherapy for early-stage larynx cancer.
    Kim HJ; Boyd J; Dunphy F; Lowe V
    Clin Nucl Med; 1998 Nov; 23(11):750-2. PubMed ID: 9814562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.
    van der Putten L; Hoekstra OS; de Bree R; Kuik DJ; Comans EF; Langendijk JA; Leemans CR
    Mol Imaging Biol; 2008 Sep; 10(5):294-303. PubMed ID: 18622649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer.
    Bongers V; Hobbelink MG; van Rijk PP; Hordijk GJ
    Cancer Biother Radiopharm; 2002 Jun; 17(3):303-6. PubMed ID: 12136522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine restaging after primary non-surgical treatment of laryngeal squamous cell carcinoma-a review.
    Seebauer CT; Hackenberg B; Grosse J; Rennert J; Jung EM; Ugele I; Michaelides I; Mehanna H; Hautmann MG; Bohr C; Künzel J
    Strahlenther Onkol; 2021 Mar; 197(3):167-176. PubMed ID: 33216194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of efficacy and clinical impact of positron emission tomography with 18F fluoro-deoxyglucose (FDG) in patients with suspicion of recurrent laryngeal carcinoma].
    Alvarez Pérez RM; Borrego Dorado I; Vázquez Albertino R; Ruiz Franco-Baux J; Ceballo Pedraja JM; Esteban Ortega F
    Acta Otorrinolaringol Esp; 2006 Mar; 57(3):134-9. PubMed ID: 16615566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.
    Roh JL; Pae KH; Choi SH; Kim JS; Lee S; Kim SB; Nam SY; Kim SY
    Eur J Surg Oncol; 2007 Aug; 33(6):790-5. PubMed ID: 17306956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.
    Cobben DC; van der Laan BF; Maas B; Vaalburg W; Suurmeijer AJ; Hoekstra HJ; Jager PL; Elsinga PH
    J Nucl Med; 2004 Feb; 45(2):226-31. PubMed ID: 14960640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.